BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 12 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $139,000 | – | 19,376 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 2,540 | $7,000 | 0.00% |
| NEXT Financial Group, Inc | 1,350 | $4,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 26,944 | $76,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,699 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $38,000 | 0.00% |
| STATE STREET CORP | 71,111 | $200,000 | 0.00% |
| MORGAN STANLEY | 60,803 | $171,000 | 0.00% |
| ARK Investment Management | 41,566 | $117,000 | 0.00% |
| JPMORGAN CHASE & CO | 152 | $0 | 0.00% |